Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia
Clinical trial NCT04289207 · UNKNOWN
Trial details
- NCT number
- NCT04289207
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2020-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.